Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/07/18
End: 09/29/19
Due: 09/29/20
Phase: N/A
Priority: Normal
Start: 09/01/19
End: 12/01/22
Due: 12/01/23
Phase: N/A
Priority: Normal
Start: 05/08/17
End: 12/28/18
Due: 12/28/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Intravitreal Aflibercept Injection or Early Vitrectomy for Diabetic Vitreous Hemorrhage | NCT04153253 | Al Hadi Hospital | user2@example.com | None | 2018-03-07 | 2019-09-29 | 2020-09-29 | - | - | 2025-07-14 |
| IVI Aflibercept Before and After Phaco in DME. | NCT05731089 | Al Hadi Hospital | user2@example.com | None | 2019-09-01 | 2022-12-01 | 2023-12-01 | - | - | 2025-07-14 |
| Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema | NCT03866746 | Al Hadi Hospital | user2@example.com | None | 2017-05-08 | 2018-12-28 | 2019-12-28 | - | - | 2025-07-14 |